Evaluation of a modified ACR20 scoring system in patients with rheumatoid arthritis receiving treatment with etanercept
- 25 May 2006
- journal article
- research article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 65 (12), 1649-1652
- https://doi.org/10.1136/ard.2005.047266
Abstract
To evaluate a modified American College of Rheumatology 20 (mACR20) scoring system for patients with rheumatoid arthritis. The data were evaluated from one study on patients with methotrexate (MTX)-naive early rheumatoid arthritis (ERA) and another study on patients with DMARD-refractory late rheumatoid arthritis (LRA). For mACR20 scoring, acute-phase reactant measurements were excluded, and 20% improvement from baseline was determined by 2 or 3 of the 4 remaining ACR components. For full joint counts with data from patients with ERA, marked differences favoured 25 mg etanercept (ETN) over 10 mg ETN by using the unmodified ACR20 (69% v 55%), the mACR20(3 of 4) (63% v 49%) and the mACR20(2 of 4) (72% v 58%). An assessment of 28 joints showed similar findings. In the trial on patients with LRA, considerably more patients in both ETN groups achieved a clinical response compared with placebo by using the ACR20, the mACR20(3 of 4) and the mACR20(2 of 4), whether using full or 28 joint counts. The mACR20(3 of 4) and full joint counts with data on patients with ERA showed a marked difference between the MTX and 10 mg ETN groups (63% v 49%), which was not observed with the ACR20. Patterns of improvement indicated by mACR20 scores were consistent with standard ACR20 scores.Keywords
This publication has 8 references indexed in Scilit:
- Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity scoreArthritis Research & Therapy, 2005
- Development and validation of the health assessment questionnaire II: A revised version of the health assessment questionnaireArthritis & Rheumatism, 2004
- Area under the curve for the American College of Rheumatology improvement criteria: A valid addition to existing criteria in rheumatoid arthritis?Arthritis & Rheumatism, 2001
- A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Etanercept Therapy in Rheumatoid ArthritisAnnals of Internal Medicine, 1999
- American college of rheumatology preliminary definition of improvement in rheumatoid arthritisArthritis & Rheumatism, 1995
- The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trialsArthritis & Rheumatism, 1993
- Analysis of improvement in individual rheumatoid arthritis patients treated with disease‐modifying antirheumatic drugs, based on the findings in patients treated with placeboArthritis & Rheumatism, 1990